Citi: FMC channel adjustments lift recovery expectations, but cash flow pressure remains intense

Why is FMC adjusting its channels?

FMC is using commercial actions to ease customers’ inventory burdens, seeking to restore normal product flows and gradually spur restocking. The company says customers have responded well because the actions lower inventory carrying costs.
Among these actions, a $175 million inventory repricing program will be implemented through credits and accounts receivable adjustments. Citi believes the measures will help improve channel health, but remains cautious about farm economics and the pace of channel recovery.
Citi notes that the related $500 million charge is primarily non-cash and mainly changes the timing of collections and rebates. According to the company, the costs of the commercial actions will be added back in debt covenant calculations, helping limit the impact on covenant and leverage metrics.

FMC reaffirmed its 2027 EBITDA guidance of $650 million to $730 million, relying on channel inventory normalization, savings from changes to its operating footprint, and growth in new active ingredients.
Citi raised its 2027 EBITDA forecast from $540 million to $579 million, still below the low end of company guidance, while cutting its fourth-quarter 2026 forecast from $231 million to $218 million.
In Citi’s base case, generic competition in Latin America and Asia will continue to pressure prices, and volume growth from new products will only partially offset the impact. Underlying revenue excluding commercial actions will be flat year over year in 2027.

Because it expects lower collections in the fourth quarter of 2026, Citi sharply cut its free cash flow forecast for the quarter from $784 million to $33 million; its full-year forecast shifted from an inflow of $72 million to an outflow of $282 million, below the low end of company guidance.
Citi also cut its 2027 free cash flow forecast from an inflow of $14 million to an outflow of $56 million. Restructuring spending will continue to exert pressure, while a recovery in volumes may also require substantial working capital.

Citi maintained its Neutral and High Risk ratings and raised its price target from $6 to $7. The valuation uses approximately 8 times forecast 2027 EV/EBITDA, down from 8.5 times previously.
Citi believes high net leverage and uncertainty over execution of the growth strategy support a lower valuation; cash flow risks, a weak agricultural economy and generic competition also keep it on the sidelines.